Peer Reviewed
Clinical case review

Patients with presumed iron overload

Lawrie Powell
Abstract
Is the treatment of patients who are heterozygous for the C282Y or H63D mutations the same as for patients homozygous for the C282Y mutation?
Key Points
    Case scenario

    The treatment of patients with haemochromatosis and iron overload who are homozygous for the C282Y mutation is straightforward. Treatment includes venesections until patients’ iron levels are reduced to within the normal range.

    What is your approach to patients with presumed iron overload (e.g. ferritin levels >600 microgram/L and transferrin saturation >60%) who are heterozygous for the C282Y or H63D mutation? Is the treatment endpoint for patients who are heterozygous for the C282Y or H63D mutation the same as for those who are homozygous for the C282Y mutation, or are these patients classed into different treatment subgroups?

Get full access
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?